Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

Similar documents
Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

Daktacort 2% / 1% w/w cream

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

ISOTREX GEL Isotretinoin 0.05% w/w

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

Retin-A 0.05% w/w cream

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

Eumovate Cream clobetasone butyrate

Dermovate Scalp Application clobetasol propionate

Dermovate Ointment clobetasol propionate

Eumovate Ointment clobetasone butyrate

What is in this leaflet 1. What Dalacin Cream is and what it is used for

Dermovate Scalp Application clobetasol propionate

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

Package Leaflet: Information for the User

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

Dermovate Ointment clobetasol propionate

PATIENT INFORMATION LEAFLET. Timodine Cream

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

DP Fusidic Acid Cream

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

4.3. Contraindications Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.

CONSUMER MEDICINE INFORMATION

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

clindamycin (as phosphate) 1% w/w and tretinoin 0.025% w/w; (klin-da-mye-sin fos-fate) and (tret- i-noin) CONSUMER MEDICINE INFORMATION

New Zealand Datasheet

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

Hair Loss Treatment Regular Strength (Minoxidil)

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

O N C E A DAY. In this leaflet FOR WOMEN

1 What Gyno-Daktarin cream is and what it is used for

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

Reference ID: CONTRAINDICATIONS None. (4)

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

SUMMARY OF PRODUCT CHARACTERISTICS

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

Item/Package Details Size Item Bottle ph Shelf Life 1.0 oz/29.6 ml 1101 Lucite Matte Silver Pump months

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

ACETOCAUSTIN 0,5 ml, Cutaneous solution

WOMEN'S Regaine EXTRA STRENGTH

Dalacin V Cream Clindamycin phosphate

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

Psoralen Tablets (Methoxypsoralen)

SIGMACORT cream and ointment

EPIDUO GEL PRODUCT INFORMATION

Occlusal 26%w/w cutaneous solution salicylic acid

A guide for patients who have been prescribed Stelara

Information PROPECIA Finasteride 1mg Tablet

v MM 130.2MM FOR WOME N O N C E A D AY

Children s Hospital Of Wisconsin

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

Package leaflet: Information for the user. Travoprost Pharmathen 40 microgram/ml, oogdruppels, oplossing Travoprost

Package leaflet: Information for the user. Fredomat 40 microgram/ml oogdruppels, oplossing. Travoprost

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BREVOXYL HYDROPHASE. Benzoyl Peroxide Cream IP

Daivobet 50/500 gel Dye-vo-bet

PRODUCT INFORMATION DIFFERIN ADAPALENE 0.1% TOPICAL GEL

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BREVOXYL CREAMY WASH. Benzoyl Peroxide Creamy Wash 4%

Patient Information Leaflet. Dermal Filler

EUMOVATE Clobetasone butyrate 0.05% w/w cream

New Zealand Datasheet. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Adapalene 0.1% topical gel

HOW TO USE. and make the most out of your CTCL treatment

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Application of Prescribed Creams/ Ointments/ Lotions (Adult)

SUMMARY OF PRODUCT CHARACTERISTICS

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

a) The diagram below shows structures within your skin. Read the list of names in the word bank and match them to the correct skin structure.

Although clindamycin phosphate is inactive in vitro, rapid in vivo hydrolysis converts this compound to the

The Leeds Teaching Hospitals NHS Trust Whole body PUVA treatment with oral psoralen

COSMETIC INTENSIVE TREATMENT (CIT) INSTRUMENTS

COPPERPEX GEL. The product for lips with herpes TOPICAL USE. Medical Device

The solution contains isopropyl alcohol 50% v/v, propylene glycol, and water.

INFORMATION ABOUT YOUR TREATMENT

Skin Reactions from Radiation Treatments

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information

Skin Allergy Testing Information

Transcription:

Package leaflet: Information for the patient Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Epiduo is and what it is used for 2. What you need to know before you use Epiduo 3. How to use Epiduo 4. Possible side effects 5. How to store Epiduo 6. Contents of the pack and other information 1. What Epiduo is and what it is used for Epiduo gel belongs to a group of medicines called anti-acne preparation for topical use i.e. it is used for the treatment of acne vulgaris, when comedones (blackheads, whiteheads), numerous papules and pustules (inflammatory pimples) are present. This gel combines two active ingredients, adapalene and benzoyl peroxide which work together but in different ways: - Adapalene belongs to a group of products known as retinoids and acts specifically on the skin processes that cause acne. - Benzoyl peroxide, works as an antimicrobial agent and by softening and peeling the outer layer of the skin. Epiduo 0.3% / 2.5% gel should only be used in adults and adolescents aged 12 years and over. 2. What you need to know before you use Epiduo Epiduo 0.3% / 2.5% gel should not be used during pregnancy or by women of childbearing potential unless they are using effective contraception (see section Pregnancy and breastfeeding ). Do not use Epiduo gel: - if you are allergic to adapalene or benzoyl peroxide or any of the other ingredients of this medicine (listed in section 6). 1

Warnings and precautions Talk to your doctor or pharmacist before using Epiduo gel. - You should not use Epiduo gel on areas where you have cuts, scrapes, sunburn or eczema. - Make sure Epiduo gel does not get into your eyes, mouth or nostrils, or mucous membranes and other very sensitive areas of the body. Should this occur wash these areas immediately with plenty of warm water. - Avoid excessive exposure to sunlight and UV lamps. - Avoid getting Epiduo gel on your hair or coloured fabrics as it may bleach them and wash your hands thoroughly after you have used Epiduo gel. If you experience persistent skin irritation when starting treatment with Epiduo gel contact your doctor (see section 3.How to use Epiduo). Other medicines and Epiduo gel - Do not use other acne products (containing benzoyl peroxide and / or retinoids) at the same time as Epiduo gel. - Avoid using Epiduo gel at the same time as cosmetics that irritate, dry or exfoliate the skin. Other medicines may have an effect on Epiduo gel, so tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. Pregnancy and breast-feeding Pregnancy Epiduo 0.3% / 2.5% gel should not be used during pregnancy or by women who plan to become pregnant. Women of childbearing potential should use effective contraception during treatment with Epiduo 0.3%/2.5% and for 1 month after discontinuation of treatment. Talk to your doctor for advice about what birth-control method to use. If you become pregnant while using Epiduo 0.3% / 2.5% gel; the treatment should be discontinued and you should inform your doctor as soon as possible for a further follow-up. Breast-feeding If you are breast-feeding ask your doctor for advice before using this medicine. Your doctor will advise you whether to discontinue breast-feeding or to abstain from treatment with Epiduo 0.3% / 2.5% gel. If your doctor advises you to continue the treatment, avoid application of the gel to the chest in order to avoid contact exposure of the infant. Driving and using machines Epiduo gel has no or negligible effects on the ability to drive and use machines. Epiduo 0.3% / 2.5% gel contains propylene glycol (E1520), an ingredient that may cause local skin irritation (e.g. contact dermatitis). 2

3. How to use Epiduo Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Epiduo 0.3% / 2.5% gel is only intended for use in adults and adolescents aged 12 years and over. Epiduo is a gel, used on the skin. The doctor will decide which strength of Epiduo gel you need, depending on the severity and appearance of your acne. The doctor will also decide if you need any additional treatment. - The skin should be clean and dry before application. - Apply a thin film of gel evenly over the entire acne-affected areas of the face and / or the trunk, once a day at bedtime. Avoid contact with the eyes, lips, nostrils and mucous membranes. - If used on the face: Wash and dry the face and use a pea size amount to cover each part of the face (e.g. forehead, chin, each cheek). - Wash your hands thoroughly immediately after you have applied Epiduo gel. Your doctor will tell you how long you will need to use Epiduo 0.3% / 2.5% gel. If you do not see any improvement after 4-8 weeks you should discuss with your doctor the benefit of continuing the treatment. If you experience persistent skin irritation during the first weeks when using Epiduo gel, contact your doctor. You may be asked to apply a moisturiser, to use the gel less often, to stop for a short time, or to stop using the gel. Do not apply cosmetics (such as other facial creams or make-up) before the daily application of Epiduo gel. These products can be used after the applied gel has dried. Use in children Epiduo 0.3% / 2.5% gel should not be used by children below 12 years of age. If you use more Epiduo gel than you should If you use more Epiduo gel than you should on your skin, you will not get rid of your acne any quicker, but your skin may become irritated and red. Please contact your doctor or the hospital if: - you have used more Epiduo gel than you should - a child has accidentally taken this medicine - you or someone else accidentally swallow this medicine. Your doctor will advise you on what action needs to be taken. If you forget to use Epiduo gel Do not apply a double dose to make up for a forgotten dose. If you stop using Epiduo gel The spots (comedones, papules and pustules) will be reduced only after several applications of this medicine. Continue using Epiduo gel as long as prescribed by your doctor. 3

If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Approximately 1 in 10 people using Epiduo 0.3% / 2.5% gel may experience adverse skin reactions. Stop using the product and seek immediate medical attention if you develop throat tightness or swelling of the eyes, face, lips or tongue, feel faint, or have difficulty breathing. Stop using the product if you develop hives or itching of the face or body. The frequency with which these side effects occur is not known. Common side effect (may affect up to 1 in 10 people): - Irritation of the skin - Eczema - Skin burning sensation Uncommon side effects (may affect up to 1 in 100 people): - Redness of the eyelid - Tingling or sensation of pins and needles at the application site - Itching of the skin, allergic skin reaction - Rash - Dry skin In addition to the side effects described above, the following side effects have been reported with a lower strength of Epiduo gel (adapalene 0.1% / benzoyl peroxide 2.5%): Uncommon - Sunburn Not known (cannot be estimated from the available data) - Swelling of the eyelid - Tightness in the throat - Allergic contact reactions - Swelling face - Pain of skin (stinging pain) - Blisters (vesicles) - Difficluty in breathing - Skin discolouration (change in skin colour) Adverse reactions typically associated with use of Epiduo include mild to moderate application site reactions, such as skin irritation with redness, dryness, scaling, stinging and or burning of the skin. If you experience persistent skin irritation during the first weeks when using Epiduo 0.3% / 2.5% gel, contact your doctor. Adverse skin-reactions, e.g. skin irritation, are more frequent with Epiduo 0.3% / 2.5 % gel than with lower strength Epiduo 0.1%/2.5 % gel. You may be asked to apply a moisturiser, to use the gel less often, to stop for a short time, or to stop using the gel. These reactions usually occur early in the treatment, and tend to gradually lessen over time. 4

Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Epiduo Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and tube/pump after EXP. The expiry date refers to the last day of that month. Do not store above 25 C. Shelf-life after first opening: 3 months Do not throw away unused Epiduo 0.3% / 2.5% gel gel via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What Epiduo 0.3% / 2.5% gel contains - The active substances are adapalene and benzoyl peroxide. One gram of gel contains 3 mg (0.3 %) adapalene and 25 mg (2.5 %) benzoyl peroxide. - The other ingredients are disodium edetate, docusate sodium, glycerol, poloxamer, propylene glycol (E1520), Simulgel 600 PHA (copolymer of acrylamide and sodium acryloyldimethyltaurate, isohexadecane, polysorbate 80, sorbitan oleate) and purified water. See end of section 2 for further information. What Epiduo 0.3% / 2.5% gel looks like and contents of the pack Epiduo gel is a white to very pale yellow opaque gel. Epiduo gel is available in: One plastic tube containing 2 or 5 grams One pump containing 15, 30, 45, or 60 grams. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder [To be completed nationally] For Sweden: Galderma Nordic AB, Seminariegatan 21, 752 28 Uppsala, Sweden Manufacturer Laboratoires Galderma Z.I. Montdésir 74540 Alby-sur-Chéran 5

France or Galderma Laboratorium GmbH Georg-Glock-Str. 8 40474 Düsseldorf Germany This medicinal product is authorised in the Member States of the EEA under the following name: Austria, Belgium, Germany, Greece, Luxembourg & Poland: Epiduo Forte Denmark: Epiduo Finland, France, Iceland, Italy, Norway, Sweden & United Kingdom: Epiduo 0.3% / 2.5% gel Spain: Epiduo Forte 3 mg/g + 25 mg/g Gel Portugal: Epiduo 3 mg/g + 25 mg/g Gel This leaflet was last revised in April 2018 6